Zealand's stock plummets after disappointing drug result. Its CEO tells CNBC people need to focus less on the 'weight loss Olympics'

The chief executive of drugmaker Zealand Pharma sought to calm investors about the latest trial results, which showed patients lost less weight than expected and prompted the stock to fall more than 35%.

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.